TN to join hands with PE/VCs to float Rs 500 cr fund for biotechnology

State Govt envisages revenue of around Rs 5,000 crore by 2016

J Jayalalithaa
Gireesh Babu Chennai
Last Updated : Mar 05 2014 | 1:42 PM IST

Tamil Nadu Government is planning to join hands with venture capital and private equity firms to float a Rs 500 crore fund for bio-technology. The fund will focus on identifying and nurturing talent and in establishing networks for effective marketing of the products of thestart-ups. The State Government also planning to create a Research Fund with a corpus of Rs 100 crore.

This is part of Tamil Nadu Government's effort to boost the biotechnology sector in the State. Last month Tamil Nadu Chief Minister J Jayalalithaa announced a new Tamil Nadu Biotechnology Policy 2014,which envisage report a revenue of around Rs 5,000 crore by 2016.

"Biotechnology offers an enormous opportunity with a vast potential and easily thetarget can be achievable," said a senior official from the Government.

One of the main focus will be helping and hand holding the start-ups,said the official. The State Government will constitute a Biotechnology Capital Fund of Rs 500 crore on public private partnership (PPP) mode, in collaboration with leading venture capital and private equity funds, who have specialised in this field, through joint ventures with Tamil Nadu Industrial Development Corporation (TIDCO), a state-run agency.

Thefund will help in identifying and nurturing talent and inestablishing networks for effective marketing of the products of thestart-ups.

Anew State Biotechnology Board will be established, which willidentify funding avenues to promote new companies.

The State Government also planning to establish a Biotechnology Research Fund, with a corpus of Rs 100 crore to begin with. The new fund would support research in thrust areas already identified and established.

It may be noted, some leading pharma companies including Pfizer, DowChemicals, Orchid Chemicals and Shasun Chemicals have established their Research & Development facilities in and around Chennai.

The State sees opportunities in vaccines and recombinant therapeutics, bioactive therapeutic proteins, steam cell, cell engineering and cell-based therapeutics, agriculture sector, animal biotechnology, contract research, clinical trials and outsourcing, bioinformatics, bio-fuels and others.

The State administration is planing to set up Department of Biotechnology and State Biotechnology Board, which will have representatives frompublic, research community, companies and state government, to foster the growth of biotechnology in the State. The Board will focus identify the areas need to be focus, establish infrastructure forresearch and manufacturing, establish specialty parks and will identify funding avenues to promote new companies.

It may be noted that Gujarat is one of the front-runners in promoting biotechnology industry and research with dedicated fund and biotechnology mission.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 05 2014 | 1:42 PM IST

Next Story